Circulatory Serum Krebs von Den Lungen-6 and Surfactant Protein-D Concentrations Predict Interstitial Lung Disease Progression and Mortality.
Meghna RaiAshwaghosha ParthasarathiNarasimha M BeerakaMohammed Kaleem UllahSowmya MalamardiSunag PadukudruJayaraj Biligere SiddaiahChinnappa A UthaiahPrashant VishwanathSindaghatta Krishnarao ChayaSubramanian RamaswamySwapna UpadhyayKoustav GangulyPadukudru Anand MaheshPublished in: Cells (2023)
There is a need for biomarkers to predict outcomes, including mortality, in interstitial lung disease (ILD). Krebs von den Lungen-6 (KL-6) and surfactant protein D (SP-D) are associated with lung damage and fibrosis in all ILDs and are related to important clinical outcomes. Though these two biomarkers have been associated with ILD outcomes, there are no studies that have evaluated their predictive potential in combination. This study aims to determine whether KL-6 and SP-D are linked to poor disease outcomes and mortality. Additionally, we plan to examine whether changes in KL-6 and SP-D concentrations correspond with changes in lung function and whether serial measurements improve their predictive potential to identify disease progression and mortality. Forty-four patients with ILD participated in a prospective 6-month longitudinal observational study. ILD patients who succumbed had the highest KL-6 levels (3990.4 U/mL (3490.0-4467.6)) and highest SP-D levels (256.1 ng/mL (217.9-260.0)), followed by those who deteriorated: KL-6 levels 1357.0 U/mL (822.6-1543.4) and SP-D levels 191.2 ng/mL (152.8-210.5). The generalized linear model (GLM) analysis demonstrated that changes in forced vital capacity (FVC), diffusing capacity of lungs for carbon monoxide (DLCO), forced expiratory volume in 1 s (FEV1), and partial pressure of arterial oxygen (PaO 2 ) were correlated to changes in KL6 ( p = 0.016, 0.014, 0.027, 0.047) and SP-D ( p = 0.008, 0.012, 0.046, 0.020), respectively. KL-6 (odds ratio (OR): 2.87 (1.06-7.79)) and SPD (OR: 1.76 (1.05-2.97)) were independent predictors of disease progression, and KL-6 (hazard ratio (HR): 3.70 (1.46-9.41)) and SPD (HR: 2.58 (1.01-6.59)) were independent predictors of death by Cox regression analysis. Combined biomarkers (KL6 + SPD + CT + FVC) had the strongest ability to predict disease progression (AUC: 0.797) and death (AUC: 0.961), on ROC analysis. Elevated KL-6 and SPD levels are vital biomarkers for predicting the severity, progression, and outcomes of ILD. High baseline levels or an increase in levels over a six-month follow-up despite treatment indicate a poor prognosis. Combining KL6 and SPD with conventional measures yields a more potent prognostic indicator. Clinical studies are needed to test additional interventions, and future research will determine if this combined biomarker benefits different ethnicities globally.
Keyphrases
- interstitial lung disease
- systemic sclerosis
- poor prognosis
- cardiovascular events
- long non coding rna
- rheumatoid arthritis
- lung function
- idiopathic pulmonary fibrosis
- computed tomography
- type diabetes
- chronic obstructive pulmonary disease
- risk factors
- cystic fibrosis
- metabolic syndrome
- magnetic resonance
- cross sectional
- risk assessment
- intensive care unit
- current status
- binding protein
- small molecule
- cardiovascular disease
- magnetic resonance imaging
- skeletal muscle
- glycemic control
- anti inflammatory
- insulin resistance
- dual energy